PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Published record starting point
- Record display name
- KLONOPIN
- Generic name / active ingredient
- clonazepam
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-09-04
Copy from the pack in hand
Source-linked reading points
- The 0.5, 1 and 2 mg figures are labelled amounts per tablet, while 100 tablets is the bottle count. Do not add these numbers or calculate today's tablet count from remaining tablets or symptoms.
- The current label directs swallowing the tablet whole with water. The 0.5 mg score is an exact-product clue, not universal permission to halve it; the current 1 mg and 2 mg products are unscored.
- Opioids, alcohol, other benzodiazepines, sleep medicines, sedating antihistamines and other CNS depressants may add effects. The label warns that opioid co-use can cause profound sedation, respiratory depression, coma and death; marked somnolence, slowed breathing, altered awareness or inability to wake requires local emergency services.
- Continued use can produce physical dependence. Abrupt stopping or rapid reduction can cause life-threatening acute withdrawal reactions, including seizures. Tapering must be individualised by a professional and cannot use one-for-one milligram conversion from VALIUM, XANAX or another benzodiazepine.
Reviewed presentation examples — compare every field
- Clonazepam 0.5 mg per tablet; 100-tablet bottleNDC 61269-605-10
- Clonazepam 1 mg per tablet; 100-tablet bottleNDC 61269-610-10
- Clonazepam 2 mg per tablet; 100-tablet bottleNDC 61269-620-10